Developer docs
API playgroundTry for free, no card

Search company profiles

Arine

Full company profile

uuid00005i4

Namestring
Arine
Legal namestring
Arine, Inc.
Websiteurl
arine.io
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Arine, Inc. is a San Francisco-based, venture-backed healthcare AI company founded in 2017 that applies artificial intelligence to medication therapy optimization for health plans, PBMs, and at-risk provider organizations. Its platform integrates clinical, behavioral, and social determinants of health (SDoH) data — including pharmacy and medical claims, cost and quality data, lab data, and contextual inputs such as voice patterns — to produce prioritized, personalized medication recommendations and care plans at population scale. The platform is delivered through a core Arine Platform and four named solution modules: LUMINATE (high-risk patient management), RESONATE (prescriber analytics), ELEVATE (quality improvement and CMS Star Ratings), and an MTM module focused on medication therapy management and care team efficiency.

Under the hood, Arine combines predictive analytics, anomaly/outlier detection, recommendation engines, process automation, and clinical knowledge retrieval in continuous-learning feedback loops, with hundreds of data features per model and reported output of more than 40 million recommendations annually across 30+ million client lives. The Arine Portal holds HITRUST Risk-based, 2-year (r2) certification, addressing healthcare security and compliance requirements demanded by health plan and provider buyers.

Arine sells primarily through an enterprise field-sales motion targeting senior clinical, pharmacy, and population-health buyers at health plans and provider systems, with quote-based, outcomes-aligned multi-year contracts rather than publicly listed pricing. Named customers include SCAN Health Plan, Oklahoma Health Care Authority, VNS Health, Desert Oasis Healthcare, and Magellan Health, and the company reports 45+ health plan clients spanning five national health plans, seven Blues plans, and two national PBMs across Medicare, Medicaid, Special Needs, and Commercial populations. The company has raised approximately $70 million across a $11M Series A (2021), $29M Series B led by 111° West Capital (August 2022), and $30M Series C led by Town Hall Ventures (June 2025), employs 101–250 people distributed across the United States, and is led by co-founders Yoona Kim, PharmD/PhD (CEO) and Penjit "Boom" Moorhead (CTO).

Short descriptiontext

Arine is a healthcare AI SaaS company that uses artificial intelligence to optimize medication therapy for health plans, PBMs, and at-risk providers by integrating clinical, behavioral, and social data into personalized medication recommendations across Medicare, Medicaid, Special Needs, and Commercial populations.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medication intelligence, medication optimization, healthcare AI platform, value-based care software, clinical decision support
Industry3 codes
PRIMARYHLACAFAJ
Patient App, Adherence & Engagement for RPM Programs
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALAIAG
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code3 codes
  • Software Publishers513210
  • Custom Computer Programming Services541511
  • Computer Systems Design Services541512
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Programming Services7371
  • Services-Computer Integrated Systems Design7373
Product category
Healthcare Medication Intelligence Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Healthcare SaaS subscriptions (value-based contracts with health plans and providers)
TypeSubscription Recurring
Description

Arine is described as a healthcare SaaS platform. Revenue comes from enterprise contracts with health plans, Blues plans, national PBMs, and at-risk provider organizations. Pricing is quote-based and outcome-aligned, evidenced by 'guaranteed outcomes', 'Immediate ROI' framing, and client outcome metrics (e.g., reduced total cost of care, reduced hospitalizations, 4-5 star ratings).

thesaasnews.com
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Quote-based enterprise pricing tied to outcomes
ModelOtherBilling cadenceMulti-year contract
Notes

Not publicly listed; outcomes-based / value-based contracts with health plans and providers.

arine.io
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1LUMINATE
Description

High-Risk Patient Management Software that uncovers opportunities to support high-risk, high-cost patients and rapidly reduce hospitalizations.

arine.io
+2 more records
Core offering1 text field

Arine provides an AI-driven medication intelligence platform that integrates clinical, behavioral, and social (SDoH) data to deliver prioritized, personalized medication recommendations for health plans and at-risk provider organizations. The platform is delivered through three core solution modules—LUMINATE for high-risk patient management, RESONATE for prescriber analytics, and ELEVATE for quality improvement and MTM—sold as recurring SaaS subscriptions with outcomes-based contracts.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 13 values shown
  • >10% decrease in Total Cost of Care
+12 more records
Product overview1 text field

Arine offers a single integrated AI-driven medication intelligence platform composed of the core Arine Platform plus three named solution modules (LUMINATE, RESONATE, and ELEVATE) that can each stand on their own or be combined to maximize impact. The core platform merges clinical, behavioral, and social data with deep clinical experience to deliver personalized medication recommendations; LUMINATE focuses on high-risk high-cost patient management, RESONATE delivers prescriber analytics to extend reach through providers, and ELEVATE drives quality improvement and Medication Therapy Management (MTM) to achieve 4-5 CMS Star Ratings. Together, the platform serves more than 45 health plans (including five National Health Plans, seven Blues Plans, and two National PBMs) and has touched more than 30 million lives while producing more than 40 million recommendations annually.

Product and service5 records
1Arine Platform (Core AI Platform)
CategoryCore Platform
Description

The underlying AI-driven medication intelligence platform that integrates clinical, behavioral, and social data (including Social Determinants of Health) with deep clinical expertise to deliver personalized medication recommendations at scale. It has touched more than 30 million lives and produces more than 40 million recommendations annually across the LUMINATE, RESONATE, and ELEVATE solutions.

2Arine LUMINATE
CategoryHigh-Risk Patient Management Software
Description

High-risk patient management solution that uses AI models leveraging hundreds of data features to identify patients at imminent risk of medication-related problems. Enables high-velocity interventions through automatically generated care plans, with reported outcomes of >40% reduction in hospitalizations and >10% decrease in total cost of care within six months.

3Arine RESONATE
CategoryPrescriber Analytics Software
Description

Prescriber analytics platform that uses AI algorithms to identify outlier prescribing patterns and deliver focused, high-impact patient recommendations to providers. Yields >50% provider recommendation acceptance rates and has demonstrated 20-30% reductions in behavioral health costs.

4Arine ELEVATE
CategoryQuality Improvement Software
Description

Quality improvement solution focused on helping health plans achieve 4-5 CMS Star Ratings across Part C and Part D measures for Medicare Advantage, Medicaid, and other populations. Analyzes social, clinical, and behavioral data to understand member risk trajectories and delivers just-in-time interventions through predictive algorithms.

5Arine Medication Therapy Management (MTM)
CategoryMedication Therapy Management Software
Description

Medication Therapy Management solution that optimizes MTM programs by automating components of medication reviews and generating member education materials and prescriber communications. Reported outcomes include 86-93% CMR completion rates and 5-10x improvement in care team efficiency performing CMRs.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierMajor Named PartnershipTypeStrategic or Co-development PartnerAnnounced on2022-08-01
Description

Named alongside Blue Shield of California as a health plan partner announced in conjunction with the Series B funding, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.

Strategic tierMajor Named PartnershipTypeStrategic or Co-development PartnerAnnounced on2022-08-01
Description

Named alongside Priority Health as a health plan partner announced with the Series B funding, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.

Strategic tierMajor Named PartnershipTypeStrategic or Co-development Partner
Description

Working with Arine on the whole patient journey for behavioral health, using data and technology to identify elevated risk between sessions. Featured in a Magellan Health webinar on behavioral health.

Strategic tierMajor Named Partnership / Flagship ClientTypeStrategic or Co-development Partner
Description

Medicare-focused health plan using Arine to deliver high-quality care to its Medicare population, achieving 92% adherence to antihypertensives and 92% CMR completion rate for MTM.

Strategic tierCompliance / Certification RelationshipTypeTechnology or Integration
Description

Arine has earned HITRUST Risk-based, 2-year (r2) Certification for its Arine Portal, demonstrating compliance with healthcare information security requirements.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

DrFirst delivers medication intelligence, e-prescribing, and clinical data solutions used by providers, health plans, and PBMs. Comparable to Arine on medication data integration and prescriber-facing workflows.

TypeBroad incumbent
Description

Surescripts operates the dominant U.S. health information network for e-prescribing and medication intelligence, used by virtually all PBMs and most health plans. Comparable to Arine as an incumbent medication data and intelligence infrastructure layer that could compete or partner.

TypeBroad incumbent
Description

Health Catalyst is a healthcare data and analytics platform serving health systems and payers on quality, cost, and value-based care. Comparable as a broad incumbent in healthcare analytics that overlaps with Arine's quality and population health modules.

TypeDirect peer
Description

Tabula Rasa HealthCare / ExactCare provides medication management, MTM, and pharmacovigilance services to health plans and at-risk provider organizations. Highly comparable on medication optimization, especially for high-risk and senior populations.

TypeBroad incumbent
Description

Olive AI deploys AI-driven workflow automation across healthcare operations, including revenue cycle and clinical workflows. Comparable to Arine as a healthcare AI platform selling into enterprise health systems, though with broader horizontal scope.

TypeDirect peer
Description

Memora Health offers AI-powered patient engagement and care navigation for health systems and payers. Comparable to Arine on AI-driven clinical workflow automation and value-based care deployments.

TypeDirect peer
Description

Cohere Health applies AI to prior authorization and utilization management for health plans. Comparable to Arine as an AI-native enterprise SaaS platform selling into payer clinical and pharmacy buyers with outcome-aligned contracts.

TypeDirect peer
Description

RxAnte is a healthcare analytics company focused on medication adherence and quality measurement for health plans and PBMs. It is the closest direct peer to Arine's adherence, Star Ratings, and MTM-focused offerings.

TypeDirect peer
Description

Bamboo Health provides real-time care coordination, behavioral health, and SDOH-informed intelligence to health plans and providers. Comparable to Arine on integrating behavioral and social data to drive medication-related and total-cost-of-care outcomes.

10Apixio (Centene)
TypeEmerging player
Description

Apixio applies AI to clinical data extraction, risk adjustment, and quality measurement for payers. Comparable to Arine on AI-driven quality and risk analytics for health plans, particularly in Medicare Advantage.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds6 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors12 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arine

Healthcare Medication Intelligence Softwarearine.io

Arine is a healthcare AI SaaS company that uses artificial intelligence to optimize medication therapy for health plans, PBMs, and at-risk providers by integrating clinical, behavioral, and social data into personalized medication recommendations across Medicare, Medicaid, Special Needs, and Commercial populations.

What Arine does

Arine, Inc. is a San Francisco-based, venture-backed healthcare AI company founded in 2017 that applies artificial intelligence to medication therapy optimization for health plans, PBMs, and at-risk provider organizations. Its platform integrates clinical, behavioral, and social determinants of health (SDoH) data — including pharmacy and medical claims, cost and quality data, lab data, and contextual inputs such as voice patterns — to produce prioritized, personalized medication recommendations and care plans at population scale. The platform is delivered through a core Arine Platform and four named solution modules: LUMINATE (high-risk patient management), RESONATE (prescriber analytics), ELEVATE (quality improvement and CMS Star Ratings), and an MTM module focused on medication therapy management and care team efficiency.

Under the hood, Arine combines predictive analytics, anomaly/outlier detection, recommendation engines, process automation, and clinical knowledge retrieval in continuous-learning feedback loops, with hundreds of data features per model and reported output of more than 40 million recommendations annually across 30+ million client lives. The Arine Portal holds HITRUST Risk-based, 2-year (r2) certification, addressing healthcare security and compliance requirements demanded by health plan and provider buyers.

Arine sells primarily through an enterprise field-sales motion targeting senior clinical, pharmacy, and population-health buyers at health plans and provider systems, with quote-based, outcomes-aligned multi-year contracts rather than publicly listed pricing. Named customers include SCAN Health Plan, Oklahoma Health Care Authority, VNS Health, Desert Oasis Healthcare, and Magellan Health, and the company reports 45+ health plan clients spanning five national health plans, seven Blues plans, and two national PBMs across Medicare, Medicaid, Special Needs, and Commercial populations. The company has raised approximately $70 million across a $11M Series A (2021), $29M Series B led by 111° West Capital (August 2022), and $30M Series C led by Town Hall Ventures (June 2025), employs 101–250 people distributed across the United States, and is led by co-founders Yoona Kim, PharmD/PhD (CEO) and Penjit "Boom" Moorhead (CTO).

Arine firmographics

Firmographics
Name
Arine
Legal name
Arine, Inc.
Website
https://arine.io
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
251–500 employees
Short description
Arine is a healthcare AI SaaS company that uses artificial intelligence to optimize medication therapy for health plans, PBMs, and at-risk providers by integrating clinical, behavioral, and social data into personalized medication recommendations across Medicare, Medicaid, Special Needs, and Commercial populations.
Ownership category
akta.pro rank

Arine industry classification

Industry
Product category
Healthcare Medication Intelligence Software
NAICS
Software Publishers (513210), Custom Computer Programming Services (541511), Computer Systems Design Services (541512)
SIC
Services-Prepackaged Software (7372), Services-Computer Programming Services (7371), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYHLACAFAJ
Patient App, Adherence & Engagement for RPM Programs
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLALAIAG
Medication Adherence & Therapy Management Platforms (refills, reminders, MTM)
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLACANAN
DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Medication intelligence
  • Medication optimization
  • Healthcare AI platform
  • Value-based care software
  • Clinical decision support

Where Arine is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arine business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Healthcare SaaS subscriptions (value-based contracts with health plans and providers): Arine is described as a healthcare SaaS platform. Revenue comes from enterprise contracts with health plans, Blues plans, national PBMs, and at-risk provider organizations. Pricing is quote-based and outcome-aligned, evidenced by 'guaranteed outcomes', 'Immediate ROI' framing, and client outcome metrics (e.g., reduced total cost of care, reduced hospitalizations, 4-5 star ratings).

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based enterprise pricing tied to outcomes

Go-to-market motion2 records

Distribution channels3 records

Marketing channels9 records

Arine product offering

Product offering

Core offering

Arine provides an AI-driven medication intelligence platform that integrates clinical, behavioral, and social (SDoH) data to deliver prioritized, personalized medication recommendations for health plans and at-risk provider organizations. The platform is delivered through three core solution modules—LUMINATE for high-risk patient management, RESONATE for prescriber analytics, and ELEVATE for quality improvement and MTM—sold as recurring SaaS subscriptions with outcomes-based contracts.

Product overview

Arine offers a single integrated AI-driven medication intelligence platform composed of the core Arine Platform plus three named solution modules (LUMINATE, RESONATE, and ELEVATE) that can each stand on their own or be combined to maximize impact. The core platform merges clinical, behavioral, and social data with deep clinical experience to deliver personalized medication recommendations; LUMINATE focuses on high-risk high-cost patient management, RESONATE delivers prescriber analytics to extend reach through providers, and ELEVATE drives quality improvement and Medication Therapy Management (MTM) to achieve 4-5 CMS Star Ratings. Together, the platform serves more than 45 health plans (including five National Health Plans, seven Blues Plans, and two National PBMs) and has touched more than 30 million lives while producing more than 40 million recommendations annually.

Differentiator

Problem solved

Functional benefit

Brands

  • LUMINATE: High-Risk Patient Management Software that uncovers opportunities to support high-risk, high-cost patients and rapidly reduce hospitalizations.
  • RESONATE
  • ELEVATE

Products and services

  • Arine Platform (Core AI Platform) The underlying AI-driven medication intelligence platform that integrates clinical, behavioral, and social data (including Social Determinants of Health) with deep clinical expertise to deliver personalized medication recommendations at scale. It has touched more than 30 million lives and produces more than 40 million recommendations annually across the LUMINATE, RESONATE, and ELEVATE solutions.
  • Arine LUMINATE High-risk patient management solution that uses AI models leveraging hundreds of data features to identify patients at imminent risk of medication-related problems. Enables high-velocity interventions through automatically generated care plans, with reported outcomes of >40% reduction in hospitalizations and >10% decrease in total cost of care within six months.
  • Arine RESONATE Prescriber analytics platform that uses AI algorithms to identify outlier prescribing patterns and deliver focused, high-impact patient recommendations to providers. Yields >50% provider recommendation acceptance rates and has demonstrated 20-30% reductions in behavioral health costs.
  • Arine ELEVATE Quality improvement solution focused on helping health plans achieve 4-5 CMS Star Ratings across Part C and Part D measures for Medicare Advantage, Medicaid, and other populations. Analyzes social, clinical, and behavioral data to understand member risk trajectories and delivers just-in-time interventions through predictive algorithms.
  • Arine Medication Therapy Management (MTM) Medication Therapy Management solution that optimizes MTM programs by automating components of medication reviews and generating member education materials and prescriber communications. Reported outcomes include 86-93% CMR completion rates and 5-10x improvement in care team efficiency performing CMRs.

Quantifiable outcome

  • >10% decrease in Total Cost of Care
  • +12 more outcomes

Companies that use Arine

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Arine technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature5 records

Arine partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered major named partnership, major named partnership / flagship client and compliance / certification relationship.

  • Priority Healthmajor named partnershipStrategic or Co-development Partner · 1 August 2022Named alongside Blue Shield of California as a health plan partner announced in conjunction with the Series B funding, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.
  • Blue Shield of Californiamajor named partnershipStrategic or Co-development Partner · 1 August 2022Named alongside Priority Health as a health plan partner announced with the Series B funding, to assist in achieving higher quality ratings across Part C and D Star measures for CMS.
  • Magellan Healthmajor named partnershipStrategic or Co-development PartnerWorking with Arine on the whole patient journey for behavioral health, using data and technology to identify elevated risk between sessions. Featured in a Magellan Health webinar on behavioral health.
  • SCAN Health Planmajor named partnership / flagship clientStrategic or Co-development PartnerMedicare-focused health plan using Arine to deliver high-quality care to its Medicare population, achieving 92% adherence to antihypertensives and 92% CMR completion rate for MTM.
  • HITRUST Alliancecompliance / certification relationshipTechnology or IntegrationArine has earned HITRUST Risk-based, 2-year (r2) Certification for its Arine Portal, demonstrating compliance with healthcare information security requirements.

Scale indicators11 records

Recent moves6 records

Expansion highlights6 records

Arine competitors and assessment

Company assessment

Direct peers

  • DrFirst: DrFirst delivers medication intelligence, e-prescribing, and clinical data solutions used by providers, health plans, and PBMs. Comparable to Arine on medication data integration and prescriber-facing workflows.
  • Tabula Rasa HealthCare (now ExactCare): Tabula Rasa HealthCare / ExactCare provides medication management, MTM, and pharmacovigilance services to health plans and at-risk provider organizations. Highly comparable on medication optimization, especially for high-risk and senior populations.
  • Memora Health: Memora Health offers AI-powered patient engagement and care navigation for health systems and payers. Comparable to Arine on AI-driven clinical workflow automation and value-based care deployments.
  • Cohere Health: Cohere Health applies AI to prior authorization and utilization management for health plans. Comparable to Arine as an AI-native enterprise SaaS platform selling into payer clinical and pharmacy buyers with outcome-aligned contracts.
  • RxAnte: RxAnte is a healthcare analytics company focused on medication adherence and quality measurement for health plans and PBMs. It is the closest direct peer to Arine's adherence, Star Ratings, and MTM-focused offerings.
  • Bamboo Health: Bamboo Health provides real-time care coordination, behavioral health, and SDOH-informed intelligence to health plans and providers. Comparable to Arine on integrating behavioral and social data to drive medication-related and total-cost-of-care outcomes.

Broad incumbents

  • Surescripts: Surescripts operates the dominant U.S. health information network for e-prescribing and medication intelligence, used by virtually all PBMs and most health plans. Comparable to Arine as an incumbent medication data and intelligence infrastructure layer that could compete or partner.
  • Health Catalyst: Health Catalyst is a healthcare data and analytics platform serving health systems and payers on quality, cost, and value-based care. Comparable as a broad incumbent in healthcare analytics that overlaps with Arine's quality and population health modules.
  • Olive AI: Olive AI deploys AI-driven workflow automation across healthcare operations, including revenue cycle and clinical workflows. Comparable to Arine as a healthcare AI platform selling into enterprise health systems, though with broader horizontal scope.

Emerging players

  • Apixio (Centene): Apixio applies AI to clinical data extraction, risk adjustment, and quality measurement for payers. Comparable to Arine on AI-driven quality and risk analytics for health plans, particularly in Medicare Advantage.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Arine social profiles

Digital presence

Arine compliance and trust

Trust signal

Compliance1 record

Arine financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arine leadership team

Management profile

Number of profiles

Profiles14 records

Arine funding detail

Funding detail

Funding overview

Funding rounds6 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arine M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arine

What does Arine do?

Arine provides an AI-driven medication intelligence platform that integrates clinical, behavioral, and social (SDoH) data to deliver prioritized, personalized medication recommendations for health plans and at-risk provider organizations. The platform is delivered through three core solution modules—LUMINATE for high-risk patient management, RESONATE for prescriber analytics, and ELEVATE for quality improvement and MTM—sold as recurring SaaS subscriptions with outcomes-based contracts.

Is Arine a public or private company?

Arine is a private company. It is classified as venture growth investor backed and is currently operating.

When was Arine founded?

Arine was founded in 2017. It employs 251 to 500 people.

Where is Arine based?

Arine is headquartered in San Francisco, United States, in the North America region.

How does Arine make money?

One revenue line is on record: healthcare SaaS subscriptions (value-based contracts with health plans and providers).

Who are Arine's main competitors?

Direct peers on record are DrFirst, Tabula Rasa HealthCare (now ExactCare), Memora Health, Cohere Health, RxAnte and Bamboo Health. Broad incumbents are Surescripts, Health Catalyst and Olive AI. Apixio (Centene) is listed as an emerging player.

Does Arine have an API?

No public API is recorded for Arine.

What industry is Arine in?

Arine's product category is Healthcare Medication Intelligence Software. Its primary akta.pro industry code is HLACAFAJ, Patient App, Adherence & Engagement for RPM Programs, with a secondary code of HLALAIAG, Medication Adherence & Therapy Management Platforms (refills, reminders, MTM). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
American City Business JournalsHow San Francisco startup Arine uses AI for medication managementSan Francisco-based startup Arine is utilizing artificial intelligence to assist healthcare providers in managing patient medications. The company has successfully raised millions of dollars to expand its service offerings and operational capabilities.HLTHArine Raises $30M Series C to Scale AI-Driven Medication OptimizationArine has secured $30 million in Series C funding led by Town Hall Ventures, alongside participation from Kaiser Permanente Ventures, bringing its total funding to $66 million. This financing aims to enhance Arine's AI-driven platform for medication optimization, which has demonstrated over 10% cost savings and 40% reduction in hospitalizations. The funding comes during a challenging time for the healthcare industry, as organizations seek innovative solutions for medication management.FinSMEsArine Raises $30M in Series CArine, an AI-driven medication intelligence company, raised $30M in Series C funding led by Town Hall Ventures, with participation from Kaiser Permanente Ventures and other existing investors. The funds will expand its specialty pharmacy management capabilities, bringing total funding to $66M.PR NewswireArine Raises Series C to Scale AI-Driven Medication Optimization and Power Value-Based OutcomesArine announced the closing of a $30 million Series C funding round led by Town Hall Ventures, with participation from Kaiser Permanente Ventures. This investment brings the company's total funding to $66 million and supports its expansion into specialty pharmacy management and AI-driven automation for healthcare providers. The capital will be used to scale Arine's platform, which focuses on medication optimization and cost savings for health plans.HIT ConsultantMDX Hawaii Taps Arine’s AI to Enhance Medication ManagementMDX Hawaii and Arine announced a partnership to integrate Arine's AI-driven medication optimization into MDX Hawaii's provider network. The collaboration aims to improve adherence and reduce adverse drug events, with Arine reporting over 40% hospitalization reduction and greater than 10% cost savings across 40+ health plans.ArineValue-Based Care for Population Health—Measure What MattersAn opinion piece argues that value-based care software, exemplified by Arine, is becoming accountable to payers for delivering measurable outcomes, especially among high-risk, high-cost populations. It cites CDC data that chronic diseases account for about 90% of the $3.8 trillion annual U.S. healthcare spend, and notes Medicare is projected to reach $1.8 trillion by 2031. The author proposes an OKR-based contract metrics framework for health plans.PR NewswireInc. 5000 Recognizes Arine as One of America's Fastest-Growing Private CompaniesArine, an AI-driven medication optimization company, was ranked 236th overall and 5th in the AI category on the 2024 Inc. 5000 list of fastest-growing U.S. private companies. The recognition highlights Arine's growth from 2020 to 2023 and its reported impact on healthcare outcomes, including a 40% reduction in hospitalizations among health plan members.Inc.How AI Helped This Founder Fix a Massive and Dangerous Problem With PrescriptionsArine, an AI-powered health technology company founded in 2017, provides a platform that analyzes patient data to recommend safer and more effective medication regimens. The company has secured significant traction with over 35 health plans and providers, including major entities like Magellan Health and Blue Cross Blue Shield, achieving 100% customer retention since its inception. Arine claims its service reduces hospitalizations by 40 percent and saves patients at least $1,500 annually by addressing the systemic issue of suboptimal prescribing.TmcnetArine Attains HITRUST Risk-Based, 2-year Certification Demonstrating the Highest Level of Information Protection AssuranceArine announced its Arine Platform on AWS has earned HITRUST Risk-Based, 2-year (r2) certification for information security. The certification meets regulatory and industry requirements, placing Arine among healthcare software organizations with this credential. The company cited its commitment to safe health data use and patient outcomes.PR NewswireArine Attains HITRUST Risk-Based, 2-year Certification Demonstrating the Highest Level of Information Protection AssuranceArine, an AI-driven SaaS platform focused on medication intelligence, announced that its platform hosted on Amazon Web Services has earned HITRUST Risk-Based, 2-year (r2) Certification, placing it among a select group of healthcare software organizations worldwide that meet these demanding regulatory compliance and industry-defined security requirements. The certification, which includes federal and state regulations and a risk-based approach, demonstrates Arine's commitment to robust cybersecurity and protecting sensitive health data. CEO Yoona Kim stated this achievement reflects Arine's dedication to information security standards for patients and healthcare clients.